Titre : Hydrogels

Hydrogels : Questions médicales fréquentes

Termes MeSH sélectionnés :

Programmed Cell Death 1 Receptor
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hydrogels : Questions médicales les plus fréquentes", "headline": "Hydrogels : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hydrogels : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-20", "dateModified": "2025-03-15", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hydrogels" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Gels", "url": "https://questionsmedicales.fr/mesh/D005782", "about": { "@type": "MedicalCondition", "name": "Gels", "code": { "@type": "MedicalCode", "code": "D005782", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D26.255.165.320" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cryogels", "alternateName": "Cryogels", "url": "https://questionsmedicales.fr/mesh/D059985", "about": { "@type": "MedicalCondition", "name": "Cryogels", "code": { "@type": "MedicalCode", "code": "D059985", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D26.255.165.320.375.187" } } } ], "about": { "@type": "MedicalCondition", "name": "Hydrogels", "alternateName": "Hydrogels", "code": { "@type": "MedicalCode", "code": "D020100", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Xuanhe Zhao", "url": "https://questionsmedicales.fr/author/Xuanhe%20Zhao", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Hyunwoo Yuk", "url": "https://questionsmedicales.fr/author/Hyunwoo%20Yuk", "affiliation": { "@type": "Organization", "name": "Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. zhaox@mit.edu." } }, { "@type": "Person", "name": "Baoyang Lu", "url": "https://questionsmedicales.fr/author/Baoyang%20Lu", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Sung-Hyuk Sunwoo", "url": "https://questionsmedicales.fr/author/Sung-Hyuk%20Sunwoo", "affiliation": { "@type": "Organization", "name": "Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul 08826, Republic of Korea." } }, { "@type": "Person", "name": "Zhangkang Li", "url": "https://questionsmedicales.fr/author/Zhangkang%20Li", "affiliation": { "@type": "Organization", "name": "Department of Biomedical Engineering, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4, Canada." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Glucagon-like peptide-1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta-analysis and meta-regression.", "datePublished": "2024-03-20", "url": "https://questionsmedicales.fr/article/38505997", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/dom.15529" } }, { "@type": "ScholarlyArticle", "name": "Netrin-1 mitigates acute lung injury by preventing the activation of the Toll-like receptor 4/nuclear factor-κB (TLR4/NF-κB) signaling.", "datePublished": "2024-02-09", "url": "https://questionsmedicales.fr/article/38345562", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.18632/aging.205527" } }, { "@type": "ScholarlyArticle", "name": "Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database.", "datePublished": "2024-02-06", "url": "https://questionsmedicales.fr/article/38390214", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fendo.2024.1330936" } }, { "@type": "ScholarlyArticle", "name": "Lupus-like membranous nephropathy during the postpartum period expressing glomerular antigens exostosin 1/exostosin 2 and phospholipase A2 receptor: a case report.", "datePublished": "2024-01-27", "url": "https://questionsmedicales.fr/article/38280123", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s13730-023-00848-w" } }, { "@type": "ScholarlyArticle", "name": "Aging changes the expression of adenosine receptors, insulin-like growth factor 1 (IGF1), and hypoxia-inducible factor 1α (HIF1α) in hypothalamic astrocyte cultures.", "datePublished": "2023-12-23", "url": "https://questionsmedicales.fr/article/38225985", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.nbas.2023.100104" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Préparations pharmaceutiques", "item": "https://questionsmedicales.fr/mesh/D004364" }, { "@type": "ListItem", "position": 3, "name": "Colloïdes", "item": "https://questionsmedicales.fr/mesh/D003102" }, { "@type": "ListItem", "position": 4, "name": "Gels", "item": "https://questionsmedicales.fr/mesh/D005782" }, { "@type": "ListItem", "position": 5, "name": "Hydrogels", "item": "https://questionsmedicales.fr/mesh/D020100" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hydrogels - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hydrogels", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hydrogels", "description": "Comment diagnostiquer une infection de plaie traitée avec un hydrogel ?\nQuels tests sont utilisés pour évaluer l'efficacité des hydrogels ?\nComment évaluer la biocompatibilité des hydrogels ?\nQuels signes indiquent une mauvaise réaction aux hydrogels ?\nComment détecter une allergie aux composants des hydrogels ?", "url": "https://questionsmedicales.fr/mesh/D020100?mesh_terms=Programmed+Cell+Death+1+Receptor&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hydrogels", "description": "Quels symptômes peuvent survenir avec l'utilisation d'hydrogels ?\nLes hydrogels peuvent-ils provoquer des douleurs ?\nComment reconnaître une infection liée à un hydrogel ?\nLes hydrogels peuvent-ils causer des démangeaisons ?\nQuels effets secondaires sont associés aux hydrogels ?", "url": "https://questionsmedicales.fr/mesh/D020100?mesh_terms=Programmed+Cell+Death+1+Receptor&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hydrogels", "description": "Comment prévenir les infections lors de l'utilisation d'hydrogels ?\nQuelles précautions prendre avec les hydrogels ?\nComment stocker les hydrogels pour éviter leur dégradation ?\nLes hydrogels nécessitent-ils une surveillance après application ?\nComment éviter les réactions allergiques aux hydrogels ?", "url": "https://questionsmedicales.fr/mesh/D020100?mesh_terms=Programmed+Cell+Death+1+Receptor&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hydrogels", "description": "Comment les hydrogels sont-ils utilisés dans le traitement des brûlures ?\nLes hydrogels sont-ils efficaces pour les ulcères ?\nPeut-on utiliser des hydrogels pour les soins post-opératoires ?\nComment les hydrogels aident-ils à traiter les plaies chroniques ?\nLes hydrogels peuvent-ils être utilisés pour les greffes de peau ?", "url": "https://questionsmedicales.fr/mesh/D020100?mesh_terms=Programmed+Cell+Death+1+Receptor&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hydrogels", "description": "Quelles complications peuvent survenir avec les hydrogels ?\nLes hydrogels peuvent-ils causer des cicatrices ?\nComment gérer une infection causée par un hydrogel ?\nLes hydrogels peuvent-ils provoquer des brûlures ?\nQuels sont les risques d'utilisation prolongée des hydrogels ?", "url": "https://questionsmedicales.fr/mesh/D020100?mesh_terms=Programmed+Cell+Death+1+Receptor&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hydrogels", "description": "Quels facteurs augmentent le risque d'infection avec les hydrogels ?\nLes personnes âgées sont-elles plus à risque avec les hydrogels ?\nLes allergies aux composants des hydrogels sont-elles fréquentes ?\nQuels antécédents médicaux augmentent les risques avec les hydrogels ?\nLes diabétiques ont-ils des risques accrus avec les hydrogels ?", "url": "https://questionsmedicales.fr/mesh/D020100?mesh_terms=Programmed+Cell+Death+1+Receptor&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection de plaie traitée avec un hydrogel ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'infection se diagnostique par l'examen clinique et des cultures de prélèvements." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'efficacité des hydrogels ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de viscosité et d'absorption d'eau sont couramment utilisés." } }, { "@type": "Question", "name": "Comment évaluer la biocompatibilité des hydrogels ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "La biocompatibilité est évaluée par des tests in vitro et in vivo sur des cellules." } }, { "@type": "Question", "name": "Quels signes indiquent une mauvaise réaction aux hydrogels ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Rougeur, gonflement ou douleur persistante peuvent indiquer une réaction indésirable." } }, { "@type": "Question", "name": "Comment détecter une allergie aux composants des hydrogels ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests cutanés ou des analyses sanguines peuvent aider à diagnostiquer une allergie." } }, { "@type": "Question", "name": "Quels symptômes peuvent survenir avec l'utilisation d'hydrogels ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Irritation, démangeaisons ou rougeurs peuvent apparaître au site d'application." } }, { "@type": "Question", "name": "Les hydrogels peuvent-ils provoquer des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs peuvent survenir si l'hydrogel provoque une réaction inflammatoire." } }, { "@type": "Question", "name": "Comment reconnaître une infection liée à un hydrogel ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Signes d'infection incluent chaleur, rougeur, écoulement purulent et douleur accrue." } }, { "@type": "Question", "name": "Les hydrogels peuvent-ils causer des démangeaisons ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des démangeaisons peuvent survenir en raison d'une réaction allergique ou d'irritation." } }, { "@type": "Question", "name": "Quels effets secondaires sont associés aux hydrogels ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure irritation, allergie ou infection locale." } }, { "@type": "Question", "name": "Comment prévenir les infections lors de l'utilisation d'hydrogels ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Assurez-vous que la plaie est propre et appliquez l'hydrogel dans des conditions stériles." } }, { "@type": "Question", "name": "Quelles précautions prendre avec les hydrogels ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Évitez d'utiliser des hydrogels périmés et suivez les instructions d'application." } }, { "@type": "Question", "name": "Comment stocker les hydrogels pour éviter leur dégradation ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Conservez-les dans un endroit frais et sec, à l'abri de la lumière directe." } }, { "@type": "Question", "name": "Les hydrogels nécessitent-ils une surveillance après application ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, surveillez régulièrement la plaie pour détecter tout signe d'infection ou d'irritation." } }, { "@type": "Question", "name": "Comment éviter les réactions allergiques aux hydrogels ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Effectuez un test cutané préalable si vous avez des antécédents d'allergies." } }, { "@type": "Question", "name": "Comment les hydrogels sont-ils utilisés dans le traitement des brûlures ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont appliqués pour hydrater la plaie et favoriser la cicatrisation tout en apaisant." } }, { "@type": "Question", "name": "Les hydrogels sont-ils efficaces pour les ulcères ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils aident à maintenir un environnement humide, favorisant la guérison des ulcères." } }, { "@type": "Question", "name": "Peut-on utiliser des hydrogels pour les soins post-opératoires ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont souvent utilisés pour protéger les incisions chirurgicales et favoriser la guérison." } }, { "@type": "Question", "name": "Comment les hydrogels aident-ils à traiter les plaies chroniques ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Ils maintiennent l'hydratation et réduisent la douleur, ce qui favorise la cicatrisation." } }, { "@type": "Question", "name": "Les hydrogels peuvent-ils être utilisés pour les greffes de peau ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent être utilisés pour protéger les greffes et maintenir l'humidité." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les hydrogels ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent infections, réactions allergiques et irritation cutanée." } }, { "@type": "Question", "name": "Les hydrogels peuvent-ils causer des cicatrices ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "En général, ils favorisent la cicatrisation, mais une mauvaise utilisation peut entraîner des cicatrices." } }, { "@type": "Question", "name": "Comment gérer une infection causée par un hydrogel ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Consultez un professionnel de santé pour un traitement approprié, souvent avec des antibiotiques." } }, { "@type": "Question", "name": "Les hydrogels peuvent-ils provoquer des brûlures ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une application incorrecte ou prolongée peut entraîner des brûlures cutanées." } }, { "@type": "Question", "name": "Quels sont les risques d'utilisation prolongée des hydrogels ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "L'utilisation prolongée peut entraîner une macération de la peau et des infections." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'infection avec les hydrogels ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent une mauvaise hygiène, des plaies profondes et un système immunitaire affaibli." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque avec les hydrogels ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent avoir une peau plus fragile et un système immunitaire affaibli." } }, { "@type": "Question", "name": "Les allergies aux composants des hydrogels sont-elles fréquentes ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les allergies sont rares, mais peuvent survenir, surtout chez les personnes sensibles." } }, { "@type": "Question", "name": "Quels antécédents médicaux augmentent les risques avec les hydrogels ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents de dermatite ou d'allergies cutanées peuvent augmenter les risques." } }, { "@type": "Question", "name": "Les diabétiques ont-ils des risques accrus avec les hydrogels ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les diabétiques peuvent avoir une cicatrisation plus lente et un risque accru d'infection." } } ] } ] }

Sources (10000 au total)

Glucagon-like peptide-1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta-analysis and meta-regression.

The cardiovascular benefits provided by glucagon-like peptide-1 receptor agonists (GLP-1RAs) extend beyond weight reduction and glycaemic control. One possible mechanism may relate to blood pressure (... A comprehensive database search for placebo-controlled randomized controlled trials on GLP-1RA treatment was conducted until December 2023. Data extraction and quality assessment were carried out, emp... Compared with placebo, GLP-1RAs modestly reduced SBP [semaglutide: MD -3.40 (95% CI -4.22 to -2.59, p < .001); liraglutide: MD -2.61 (95% CI -3.48 to -1.74, p < .001); dulaglutide: MD -1.46 (95% CI -2... Patients on GLP-1RA experienced modest SBP lowering compared with placebo. This observed effect was associated with weight/body mass index reduction and better glycaemic control, which suggests that B...

Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database.

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are widely used due to their profound efficacy in glycemic control and weight management. Within real-world contexts, the manifestation of certain... We retrieved reports of AEs associated with treatment with GLP-1 RAs during the period from the first quarter (Q1) of 2004 to Q1 2023 from the FDA Adverse Event Reporting System (FAERS) database. Desc... A total of 8,240 reports of psychiatric AEs were analyzed out of 181,238 AE reports with treatment with GLP-1 RAs. Among these cases, a higher percentage was represented by women compared to men (65.8... Our findings demonstrate a significant association between GLP-1 RAs and the development of specific psychiatric AEs. Despite the observational nature of this pharmacovigilance study and the inherent ...

Extracellular tau stimulates phagocytosis of living neurons by activated microglia via Toll-like 4 receptor-NLRP3 inflammasome-caspase-1 signalling axis.

In tauopathies, abnormal deposition of intracellular tau protein followed by gradual elevation of tau in cerebrospinal fluids and neuronal loss has been documented, however, the mechanism how actually...

Relationship Between Angiotensin II Type 1 Receptor Antibody Positivity and Cytokine Gene Polymorphism in Renal Transplant Patients When Organ Rejection Occurs.

Kidney transplant remains the gold standard for the treatment of end-stage renal disease. Relationships between the presence of non-HLA antibodies, antibodies to AT1R, and cytokine gene polymorphisms ... Our study included 100 pediatric and adult kidney transplant patients plus 50 healthy controls. Levels of AT1R antibodies (by enzyme-linked immunosorbent assay) and gene polymorphisms of the cytokines... We found no statistically significant relationship between levels of antibodies to AT1R and gene polymorphisms among the studied cytokines in patients with rejection compared with the healthy controls... Because we observed that some gene polymorphisms among the studied cytokines may affect AT1R antibody levels, future studies are needed to understand the mechanism of the relationship. In addition, st...

Hypoglycemia Risk With SGLT2 Inhibitors or Glucagon-Like Peptide 1 Receptor Agonists Versus Sulfonylureas Among Medicare Insured Adults With CKD in the United States.

Information on safety issues of newer glucose-lowering medications from a large population perspective in chronic kidney disease (CKD) patients with type 2 diabetes is limited. Our study aimed to exam... Retrospective cohort.... The 20% random sample of Medicare fee-for-service claims, 2012-2018.... Use of SGLT2is, GLP-1RAs, or sulfonylureas.... Hypoglycemic events resulting in health care utilization.... Cox proportional hazard model evaluated the 90-day risk of hypoglycemia associated with SGLT2is or GLP-1RAs versus sulfonylureas.... A total of 18,567 adults (mean age: 73 years) with CKD and type 2 diabetes was included; 14.0% (... CKD and type 2 diabetes diagnosis, CKD stage, and patient clinical status were identified with diagnosis or procedure codes. There is potential for residual confounding with use of retrospective data.... Use of SGLT2is or GLP-1RAs compared with sulfonylureas was associated with a lower risk of hypoglycemia among patients with CKD and type 2 diabetes. Black race was not only associated with lower use o...